Single-Center Retrospective Study Assessing the Efficacy and Safety of BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) As Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation

This observational retrospective single-center study reported the efficacy and safety of the BeEAM regimen. 55 patients with diffuse large B cell lymphoma, Hodgkin lymphoma, mantle cell lymphoma, or follicular lymphoma were included.